Form 4 for CVS CVS Health
Accepted 2022-09-02 00:00:00 ET · period of report 2022-08-31 · accession 0001127602-22-022030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-02 | 2022-08-31 | CVS | Mandadi Tilak | EVP, CTO | A - Grant | $0.00 | +99.8K | 99.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSU) | 2022-08-31 | A | A | 99,847 | $0.00 | 99,847 | D | — | — | (F1) Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023. |